CDMO AGC Biologics has put the finishing touches on an expansion of its facility in Milan, Italy.
The facility, named AGC’s Milan Cell & Gene Center of Excellence, is a manufacturing site designated to produce viral vectors for customers. The site includes a new filling line, more lab space and warehousing facilities.
AGC acquired the site in July 2020 to boost its cell and gene business. The CDMO currently has another cell and gene facility in Longmont, CO.
“When you combine this with our development, analytical and fill/finish services, this site can offer cell and gene developers any type of support they need throughout their product’s lifecycle,” Luca Alberici, general manager of AGC Biologics Milan, said in a release.
Charles River Laboratories sees a spike in its Q2 numbers
Charles River has pulled in $1.06 billion in the second quarter of 2023, an 8.9% bump from…
Click here to view original post
